CVS Health Corp <CVS.N>: Leerink Partners raises target price to $119 from $110
CVS•Related News
Syntec Optics receives new orders for two additional AR defense display windows
OPTX•
BNB Plus stock set to shift to OTCQB as Nasdaq suspends trading July 14 after delisting ruling
BNBX•
Dollar wavers amid renewed Iran attacks, yen slides on pensions doubts
TLT•
Hayward updates financial calendar with second-quarter earnings release and conference call
HAYW•
Kamada targets higher CYTOGAM use as post-marketing studies expand in lung transplant CMV prophylaxis
KMDA•